STOCK TITAN

Certara to Report Fourth Quarter and Full Year 2022 Financial Results on March 1st, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Certara, Inc. (Nasdaq: CERT), renowned for its biosimulation expertise, has announced it will disclose its financial results for the fourth quarter and full year of 2022 post-market on March 1, 2023. The company will host a conference call at 5:00 p.m. ET to discuss these results. Interested investors can register in advance to listen live, with an archive available afterward. Certara provides innovative biosimulation software and services to a global clientele that includes over 2,000 biopharmaceutical firms, academic institutions, and regulatory bodies.

Positive
  • The upcoming earnings report may provide insights into future growth and performance metrics.
  • Certara serves over 2,000 clients globally, indicating strong market penetration.
Negative
  • None.

PRINCETON, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the fourth quarter and full year of 2022 after the market close on Wednesday, March 1st, 2023. Company management will host a conference call to discuss financial results at 5:00 p.m. ET.

Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com/.

About Certara
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries. Visit us at www.certara.com.

Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com

Media Contact:
Daniel Yunger
Kekst CNC
daniel.yunger@kekstcnc.com


FAQ

When will Certara release its Q4 and full year 2022 financial results?

Certara will release its financial results after the market close on March 1, 2023.

What time is the Certara conference call for discussing the financial results?

The conference call will take place at 5:00 p.m. ET on March 1, 2023.

How can investors listen to Certara's financial results conference call?

Investors can listen by registering online at least a day in advance.

What services does Certara provide to its clients?

Certara offers proprietary biosimulation software and services that enhance drug discovery and development.

Certara, Inc.

NASDAQ:CERT

CERT Rankings

CERT Latest News

CERT Stock Data

1.73B
120.32M
2.6%
95.88%
3.08%
Health Information Services
Services-prepackaged Software
Link
United States of America
RADNOR